Phase II study evaluating the efficacy and safety of CNTO328 in combination with dexamethasone for patients with relapsed/refractory multiple myeloma (MM)

G. Somlo, H. Xie, J. T. Vermeulen, R. F. Manges, P. M. Voorhees, P. Sonneveld, R. Z. Orlowski, S. Zweegman, M. Munteanu, S. Jagannath

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)8593-8593
Number of pages1
JournalJournal of Clinical Oncology
Issue number15_suppl
Publication statusPublished - 24 Feb 2017

Cite this